$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Sertraline salts and sustained-release dosage forms of sertraline 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/26
  • A61K-009/44
  • A61K-009/52
  • A61K-009/54
출원번호 US-0380897 (1999-09-07)
국제출원번호 PCT/IB98/00934 (1998-06-15)
국제공개번호 WO99/01121 (1999-01-14)
발명자 / 주소
  • Am Ende, Mary Tanya
  • Curatolo, William John
  • Friedman, Hylar Lewis
  • Friesen, Dwayne Thomas
  • Herbig, Scott Max
  • Shankar, Ravi Mysore
  • West, James Blair
출원인 / 주소
  • Pfizer Inc.
대리인 / 주소
    Richardson, Peter C.Benson, Gregg C.O'Gorman, Carmella A.
인용정보 피인용 횟수 : 29  인용 특허 : 26

초록

Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr.

대표청구항 ▼

Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr. ) is carried out at temperatures below 30° C. 21. A cosmetic antipers

이 특허에 인용된 특허 (26)

  1. Robertson David W. (Greenwood IN) Wong David T. (Indianapolis IN), 1-Phenylalkylamines as selective serotonin uptake inhibitors.
    상세보기
  2. Robertson David W. (Greenwood IN) Wong David T. (Indianapolis IN) Thompson Dennis C. (Indianapolis IN), 1-phenyl-3-naphthalenyloxypropanamines and their use as selective serotonin reuptake inhibitors.
    상세보기
  3. Welch, Jr., Willard M.; Harbert, Charles A.; Koe, B. Kenneth; Kraska, Allen R., Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine.
    상세보기
  4. Howard Harry R. (New York NY) Macor John E. (New York NY) Chenard Bertrand L. (New York NY) Sprouse Jeffrey S. (New York NY) Schulz David W. (New York NY), Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist.
    상세보기
  5. Ranade Gautam R. (East Lyme CT), Controlled release device for an active substance.
    상세보기
  6. Ranade Gautam R. (East Lyme CT), Generic zero order controlled drug delivery system.
    상세보기
  7. Thomas Peter G., Histidine compositions and methods for treating or preventing infectious and non-infectious diarrheas.
    상세보기
  8. Shannon Harlan E. ; Womer Daniel E., Method for treating pain.
    상세보기
  9. Doogan Declan P. (Canterbury NY GB2) Scappaticci Karen A. (New York NY) Hackett Elizabeth (New York NY), Method of treating anxiety-related disorders using sertraline.
    상세보기
  10. Bacopoulos Nicholas G. (Stonington CT) Blick Peter A. (Los Gatos CA) Koe B. Kenneth (Ferry CT) Norris Evan R. (Chappaqua NY), Method of treating chemical dependencies using sertraline.
    상세보기
  11. Bick Peter A. (Hartsdale NY), Method of treating premature ejaculation using sertraline.
    상세보기
  12. Young James W. (Still River MA) Barberich Timothy J. (Concord MA), Methods and compositions for treating depression using optically pure fluoxetine.
    상세보기
  13. Wurtman Richard J. (Boston MA) Wurtman Judith J. (Boston MA), Methods for treating the premenstrual or late luteal phase syndrome.
    상세보기
  14. Thakkar Arvind L. (Indianapolis IN) Gibson Lowell L. (Beech Grove IN), Orally administerable sustained release pharmaceutical formulation.
    상세보기
  15. Thakkar Arvind L. (Indianapolis IN) Gibson Lowell L. (Beech Grove IN), Orally administerable sustained release pharmaceutical formulations.
    상세보기
  16. Thakkar Arvind L. (Indianapolis IN) Gibson Lowell L. (Beech Grove IN), Orally administerable sustained release pharmaceutical formulations.
    상세보기
  17. Quallich George J. (North Stonington CT) Williams Michael T. (Deal GB2), Process for preparing a 4,4-diphenylbutanoic acid derivative.
    상세보기
  18. Spavins James C. (North Stonington CT), Process for preparing a ketimine.
    상세보기
  19. Quallich George J. (North Stonington CT), Process for preparing ketone enantiomer.
    상세보기
  20. Quallich George J. (North Stonington CT) Williams Michael T. (Deal GB2), Process for preparing sertraline intermediates.
    상세보기
  21. Nixon James A. (Indianapolis IN) Pioch Richard P. (Indianapolis IN) Schaus John M. (Indianapolis IN) Titus Robert D. (Indianapolis IN), Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes.
    상세보기
  22. Schaus John M. (Indianapolis IN) Titus Robert D. (Indianapolis IN), Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes.
    상세보기
  23. Sysko Robert J. (Niantic CT) Allen Douglas J. M. (New London CT), Sertraline polymorph.
    상세보기
  24. Ruppert Heinrich W. (Trossingen DEX) Gtschmann Klaus G. (Trossingen DEX), Tobacco product for the personal preparation of a cigarette, in particular filter cigarette.
    상세보기
  25. Koe B. Kenneth (Gales Ferry CT), Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of inflammation and as immunosuppressa.
    상세보기
  26. Johnson Anthony M. (Welwyn GB2), Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia.
    상세보기

이 특허를 인용한 특허 (29)

  1. Tygesen, Peter Holm; Lindhardt, Karsten; Olsen, Martin Rex; Fischer, Gina Engslev; Overgard, Jan Martin; Boye, Georg; Skak, Nikolaj; Elhauge, Torben, Abuse deterrent pharmaceutical compositions for controlled release.
    상세보기
  2. Tygesen, Peter Holm; Lindhardt, Karsten; Olsen, Martin Rex; Fischer, Gina Engslev; Overgard, Jan Martin; Boye, Georg; Skak, Nikolaj; Elhauge, Torben, Abuse-deterrent pharmaceutical compositions for controlled release.
    상세보기
  3. Bar-Shalom, Daniel, Controlled release composition.
    상세보기
  4. Hemmingsen, Pernille Hoyrup; Pedersen, Anders Vagno; Bar-Shalom, Daniel, Controlled release pharmaceutical compositions for prolonged effect.
    상세보기
  5. Andersen, Christine; Lindhardt, Karsten; Oevergaard, Jan Martin; Lyhne-Iversen, Louise Inoka; Olsen, Martin Rex; Haahr, Anne-Mette; Hoeyrup Hemmingsen, Pernille Kristine, Formulations and methods for the controlled release of active drug substances.
    상세보기
  6. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Fragmented hydrogels.
    상세보기
  7. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
    상세보기
  8. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
    상세보기
  9. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
    상세보기
  10. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
    상세보기
  11. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
    상세보기
  12. Tygesen, Peter Holm; Oevergaard, Jan Martin; Oestman, Joakim, Immediate release composition resistant to abuse by intake of alcohol.
    상세보기
  13. Thor, Karl Bruce, Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction.
    상세보기
  14. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
    상세보기
  15. Fischer, Gina; Bar-Shalom, Daneil; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
    상세보기
  16. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
    상세보기
  17. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine controlled release system.
    상세보기
  18. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine polymer release system.
    상세보기
  19. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Morphine polymer release system.
    상세보기
  20. Miller, Fred H., Multi-phase, multi-compartment capsular delivery apparatus and methods for using same.
    상세보기
  21. Miller, Fred H., Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same.
    상세보기
  22. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Andersen, Christine, Opioid polymer release system.
    상세보기
  23. Ajani, Mauro; Bozzella, Roberta; Celasco, Giuseppe; Villa, Roberto, Oral antimicrobial pharmaceutical compositions.
    상세보기
  24. Brown, Adrian; Matthews, Wayne M.; Margetson, Daniel M.; McAllister, Stephen Mark; Raby, Ronald K., Pharmaceutical formulations.
    상세보기
  25. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie; Andersen, Christine, Polymer release system.
    상세보기
  26. Fischer, Gina; Bar-Shalom, Daniel; Slot, Lillian; Lademann, Anne-Marie; Andersen, Christine, Polymer release system.
    상세보기
  27. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Polysaccharide based hydrogels.
    상세보기
  28. Remenar,Julius; MacPhee,Michael; Peterson,Matthew Lynn; Tawa,Mark, Sertraline compositions.
    상세보기
  29. Seed, Brian; Mechanic, Jordan, Treating psychological conditions using muscarinic receptor M1 antagonists.
    상세보기

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로